COMMUNIQUÉS West-GlobeNewswire

OncoC4 Selected to Present at the 2025 AACR Meeting's Showcase Session
16/04/2025
Oral presentation will feature AI-081, a potentially best-in-class PD-1/VEGF bispecific antibody and ONC-841, a first-in-class anti-Siglec-10 antibody Initial clinical data for both AI-081 and ONC-841 in solid tumors [...]
Patent Granted to BC3 Technologies for SEAL Hemostatic Wound Spray
16/04/2025
-- FDA-Cleared Aerosolized Chitosan Hemostatic Agent Receives Patent for its Innovative Material and Method -- BALTIMORE, April 16, 2025 (GLOBE NEWSWIRE) -- BC3 Technologies, a Baltimore-based, minority-owned company [...]
Cocrystal Pharma to Present at Life Science Innovation Northwest 2025 Conference
16/04/2025
BOTHELL, Wash., April 16, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc . (Nasdaq: COCP) announces that Sam Lee, President and co-CEO, will present a Company overview at the Life Science Innovation Northwest (LSINW) [...]
electroCore to Participate at the Planet MicroCap Showcase
16/04/2025
ROCKAWAY, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Planet [...]
Nautilus Biotechnology to Announce First Quarter 2025 Financial Results on April 29, 2025
16/04/2025
SEATTLE, April 16, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today announced it will report financial results [...]
Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update
16/04/2025
Advancing development of next-generation precision Antibody Drug Conjugates (ADCs) to address multiple indications across a range of cancer types Continued progress of lead program, AKTX-101, for the treatment of solid [...]
Addgene Adds Science and Tech Leaders to Its Management Team and Board of Directors
16/04/2025
Strategic appointments advance Addgene’s growth and market expansion strategy WATERTOWN, Mass., April 16, 2025 (GLOBE NEWSWIRE) -- Addgene , an organization empowering discovery by providing scientists with a vast [...]
Glucotrack to Participate in FORGETDIABETES, a Prominent European Research Initiative to Develop a Bionic Pancreas
16/04/2025
Continuous Blood Glucose Monitor will be integrated with automated insulin delivery system for major EU diabetes study RUTHERFORD, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) (“Glucotrack” [...]
Vaxartto Present at World Vaccine Congress Washington 2025 on April 23
16/04/2025
SOUTH SAN FRANCISCO, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) today announced that Dr. Sean Tucker, Founder and Chief Scientific Officer, and Dr. James F. Cummings, Chief Medical Officer, [...]
Best Appetite Suppressants - Natural Over the Counter (OTC) Appetite Suppressant for Hunger Control & Fat Burner ( Men & Women) - By Phenq CrazyBulk in USA
16/04/2025
Albany, New York, April 16, 2025 (GLOBE NEWSWIRE) -- Struggling to control your appetite and cravings? You're not alone. Maintaining a healthy weight can be a constant battle in the modern world of tempting high-calorie [...]
BriaCell Phase 2 Survival Data Beats Leading Standard in HR+ Breast Cancer
16/04/2025
Median overall survival of 17.3 months in Bria-IMT™ treated patients with hormone receptor positive (HR+) metastatic breast cancer markedly exceeds historical data of 14.4 months in TRODELVY ® (sacituzumab govitecan- [...]
LAVA Therapeutics Granted Full Waiver for RVO Payment Obligation
16/04/2025
Exemption from the $5.1 million repayment obligation strengthens LAVA’s balance sheet Underscores focus on cost curtailment and strategic option evaluation UTRECHT, The Netherlands and PHILADELPHIA, April 16, 2025 ( [...]
Avicanna Announces Revocation of Management Cease Trade Order
16/04/2025
TORONTO, April 16, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or “ Company ”) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing, and commercialization [...]
Oxford Scientists Reveal Sunlight-Powered Anti-Cancer Breakthrough
16/04/2025
OXFORD, United Kingdom, April 16, 2025 (GLOBE NEWSWIRE) -- Dr. Daniel Chen, at the University of Oxford and Chief Scientist at biotech startup Oxperial BioHealth , revealed their major breakthrough in cancer prevention— [...]
Cullinan Therapeutics Receives Approval from European Medicines Agency to Initiate Phase 1 Trial of CLN-978, a Bispecific CD19 T Cell Engager Administered Subcutaneously, in Patients with Rheumatoid Arthritis
16/04/2025
Company-sponsored clinical trial will be initiated at FAU Erlangen-Nuremberg in Germany and Università Cattolica del Sacro Cuore, Rome in Q2 2025 CLN-978 is also being studied in the U.S., Europe, and Australia for [...]
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
16/04/2025
WATERTOWN, Mass., April 16, 2025 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients with serious [...]
Tilray Brands Ranks #4 on the Brewers Association List of Top Producing Craft Brewers in the United States
16/04/2025
Tilray Beverages Climbs to #4! Cheers to Ranking Among the Top Craft Brewers in the U.S.! NEW YORK, April 16, 2025 (GLOBE NEWSWIRE) -- Tilray Beverages, a division of Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), is [...]
Madrigal Pharmaceuticals Announces Company Founder Rebecca Taub, M.D. to Become Senior Scientific and Medical Advisor; David Soergel, M.D., Appointed Chief Medical Officer
16/04/2025
Dr. Taub’s pioneering research in academia and industry led to the first FDA-approved therapy for patients with MASH CONSHOHOCKEN, Pa., April 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL), a [...]
INmune Bio Receives Favorable Patentability Opinion for CORDStrom™ Platform Technology
16/04/2025
Boca Raton, Florida, US, April 16, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB), a clinical-stage biotechnology company targeting inflammation and immunology through the innate immune system, today announced [...]

Pages